VBL Therapeutics Announces Publication of Phase 2 and Phase 3 Data of VB-111 in Recurrent Glioblastoma Supporting Continued Development in Investigator-Sponsored Study

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling